Literature DB >> 779765

Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl-peptides or -amino acids.

S Kotani, Y Watanabe, T Shimono, K Harada, T Shiba.   

Abstract

A total of 14 different N-acetylmuramyl-peptides or -amino acids with or without configurations inherent to bacterial cell wall peptidoglycans were synthesized and their pyrogenicities on intravenous injection into rabbits were tested. N-Acetylmuramyl-peptides, and especially N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylmuramyl-L-alanyl-D-isoglutaminyl-L-lysine, which were previously shown to be adjuvant-active in both induction of delayed-type hypersensitivity and stimulation of increased serum antibody levels to ovalbumin in guinea pigs, exhibited distinct pyrogenicity at as low dose as 16 mug per rabbit. However, none of the adjuvant-inactive analogues or diastereomers of the above N-acetylmuramyl-dipeptide or related compounds caused any significant febrile response in rabbits, even at a dose of 250 mug per animal.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 779765

Source DB:  PubMed          Journal:  Biken J        ISSN: 0006-2324


  30 in total

1.  Gut flora induces and maintains resistance against streptococcal cell wall-induced arthritis in F344 rats.

Authors:  M F van den Broek; M C van Bruggen; J P Koopman; M P Hazenberg; W B van den Berg
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 2.  Rheumatoid arthritis: review of searches for an infectious cause. Part II.

Authors:  E Wilkes; E S Meek
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptide.

Authors:  L T Meltzer; K A Serpa; W H Moos
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs.

Authors:  M Uemiya; K Sugimura; T Kusama; I Saiki; M Yamawaki; I Azuma; Y Yamamura
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

5.  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Authors:  L Chedid; M Parant; F Parant; P Lefrancher; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

6.  Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.

Authors:  A Tanaka; S Nagao; R Nagao; S Kotani; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

7.  Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.

Authors:  M Parant; F Parant; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

8.  Stimulatory effect of N-acetyl Muramyl dipeptide in vivo: proliferation of bone marrow progenitor cells in mice.

Authors:  B Wuest; E D Wachsmuth
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP.

Authors:  L Chedid; F Audibert
Journal:  Springer Semin Immunopathol       Date:  1985

10.  Comparison of immunomodulatory activities in mice and guinea pigs of a synthetic desmuramyl peptidolipid triglymyc.

Authors:  C D Leclerc; F M Audibert; L A Chedid; E J Deriaud; N K Masihi; E Lederer
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.